feed,title,long_url,short_url
Benzinga,Why Scholar Rock Shares Dropped Despite Positive Apitegromab Data In Spinal Muscular Atrophy,https://benzinga.com/general/biotech/21/04/20503711/why-scholar-rock-shares-dropped-despite-positive-apitegromab-data-in-spinal-muscular-atrophy,https://j.mp/3rTet1F
